Key result
Heterophilic antibody interference with the CARDIAC T Quantitative Rapid Assay highlights the need for careful evaluation of new LightCycler genotyping assays and controls for each genotype.
Key points are not available for this paper at this time.
May warrant troponin verification in suspected interference cases; leaves open optimal LightCycler genotyping controls.
Our findings suggest the value of careful evaluation of new LightCycler genotyping assays and of controls for each genotype.
No takes yet. Share an insight, caveat, or question.
White et al. (2002) studied this question. Heterophilic antibody interference with the CARDIAC T Quantitative Rapid Assay highlights the need for careful evaluation of new LightCycler genotyping assays and controls for each genotype.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: